ReviewNPJ precision oncology2023
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
Aditya Shreenivas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
73 papers cite itlatest 60 shown
this papertrialcites it
ReviewNPJ precision oncology2023
Aditya Shreenivas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.